Stocks股票 / Health Care / INDV

Indivior · Health Care

INDV US listed · USD美股 · 美元

Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction.Indivior是一家美国制药公司,最初于1994年作为利洁时集团的分部成立,并于2014年12月从该公司分拆,专注于阿片类药物成瘾的替代产品。

Mid cap中盘 · $5B Mixed profile混合特征 Health Care S&P 600标普600小盘Russell 2000罗素2000
$39.12
-$1.42 · -3.50%
52w low52周低 $15.34high $42.43
Constructive — building a base建设性 — 正在筑底 Setup almost complete — likely buy trigger in ~1–3 trading days if it closes back above its 10-day average.形态接近完成——若收盘重新站上 10 日均线,预计将在约 1–3 个交易日内出现买入触发。 Engine read引擎解读 · 2026-07-21

Price chart价格图表

daily · interactive日线 · 可交互 Open in Terminal打开终端
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。 Open the live chart in Terminal在终端中打开实时图表
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。 MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动

Technicals技术面

daily bars日线数据 · 2026-07-21
Momentum (RSI 14)动量(RSI 14) 46
Neutral zone中性区域
vs 50-day average相对50日均线 +1.1% above上方 Uptrend intact趋势完好
vs 200-day average相对200日均线 +16.0% above上方 Long trend up长期向上
Volatility波动率 41th percentile第41百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源,每晚更新。

Earnings财务业绩

next report下次财报 2026-07-30
10days to go天后公布

Estimates being raised — 4 analysts预期上调 — 4 位分析师

Valuation估值

Roughly fair vs sector相对行业估值合理
Multiple指标INDV Sector median行业中位Cheaper than相对便宜
P/E (trailing)市盈率(历史) 23.30x 28.59 64%
P/S市销率 3.95x 2.97 38%
Earnings yield盈利收益率 4.29% 2.72 74%
FCF yield自由现金流收益率 -1.90% 4.00 10%
Shareholder yield股东收益率 0.22% 1.89 16%
EV/EBITDA企业价值/EBITDA 18.44x 18.18 49%
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。

Financials财务数据

fiscal years财年
Revenue营业收入
$1.2B2024
$1.2B2025
5-yr growth5年复合增速 4.3%
Earnings per share每股收益
$0.022024
$1.642025
5-yr growth5年复合增速 8100.0%
Free cash flow自由现金流
$7.0M2024
-$93.0M2025
Gross margin毛利率
80.2%
Operating margin营业利润率
21.1%
Net margin净利率
16.9%
FCF margin自由现金流利润率
-2.2%
Balance-sheet quality财务体质 3/8 Bankruptcy risk: safe zone破产风险:安全区 Return on equity股本回报率 -214% Watch关注

Leverage杠杆

Net debt / EBITDA净债务/EBITDA0.46
Current ratio流动比率0.71

Capital allocation资本配置

Buybacks (TTM)回购(TTM)$11.0M
Stock-based comp股权薪酬$26.0M

Why is it moving为何波动

6 checks · nightly六项检查 · 每晚
Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Insider cluster activity内部人集中交易
Technical技术面 BOTTOMING → NEARING A HIGH筑底中 → 接近高点

Ownership & smart money持仓与聪明钱

13F

Insider activity:内部人动向: +$0.2M net (6 buyers, 0 sellers)+$0.2M 净值(6 买家,0 卖家)

Fund基金Grade评级 Latest move最新动作% of book组合占比As of截至
Oaktree Capital Management B exitexit 0.1% 2026-03-31
Soros Fund Management B exitexit 0.0% 2026-03-31

Signal history信号历史

engine events引擎事件
NEARING A HIGH → BOTTOMING接近高点 → 筑底中 BUY SETUP. Buyers rejected the 2026-06-17 low (swing low printed) but price hasn't reclaimed its 10-day average — first box ticked, not all买入预备。买方拒绝了 2026-06-17 的低点(摆动低点已现),但价格尚未收复 10 日均线——第一项条件达成,并非全部
Jul 15, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 10, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 8, 2026
INDV StochRSI turned up from oversoldINDV StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $40.89.StochRSI重回20上方 — 下行动量趋缓的最早预警。$40.89。
Jul 7, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 7, 2026
INDV took relative-strength leadershipINDV 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $40.83.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$40.83。
Jul 6, 2026
INDV daily MACD crossed downINDV 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $39.99.日线MACD柱状图转负 — 快速且嘈杂,仅作背景。$39.99。
Jul 2, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jun 29, 2026
NEARING A HIGH → UPTREND接近高点 → 上涨趋势
HOLD持有
Showing the last 15 of显示最近15条,共 236 signals条信号

Company profile公司档案

Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction.Indivior是一家美国制药公司,最初于1994年作为利洁时集团的分部成立,并于2014年12月从该公司分拆,专注于阿片类药物成瘾的替代产品。

Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Profitability盈利能力
Above market高于市场
Quality质量
Below market低于市场
Investment资本投入
Above market高于市场
Shareholder payout股东回报
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Above market高于市场
Earnings quality盈利质量
Above market高于市场
Short interest空头兴趣
Above market高于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
  • Margin compression despite revenue growth

The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。

Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。

Browse all stocks浏览所有股票 Open Terminal打开终端

Research context only — not investment advice. Past patterns do not guarantee future results.仅供研究参考,不构成投资建议。历史规律不代表未来表现。

Data through数据截至 2026-07-21 · regenerated nightly每晚更新 · Generated生成于 2026-07-21 02:08 UTC · All coverage所有股票 · Analyzer分析器